Verzele Pharma SRL
2.0 FTEVerzele Pharma reported total assets of 500,597 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026), with 2 full-time equivalents.
The score of Verzele Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +13 % Total assets -21 % Headcount (avg FTE) 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Verzele Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 38,414 € | ||||
| Equity | 166,349 € | ||||
| Cash | 169,128 € | ||||
| EBITDA | 64,912 € | ||||
| Total assets | 500,597 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 24 Aug 2022
Verzele Pharma's financial analysis
- Solvency33.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Verzele Pharma
Verzele Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.764.703
- VAT number
- BE0896764703
- Peppol
- Registered · 0208:0896764703 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 28 Mar 2008
- Registered office
- 9700 Oudenaarde
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Verzele Pharma (SRL) has been based in Oudenaarde since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 38,414 € and equity of 166,349 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 33.2%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Verzele Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek RH Retail sale of pharmaceutical products Antwerp · balance sheet 500,314 €
- Pharmaproducts Retail sale of pharmaceutical products Heusden-Zolder · balance sheet 501,031 €
- Pharmacie Depoitte Retail sale of pharmaceutical products Grâce-Hollogne · balance sheet 501,536 €
- HCL Pharma Retail sale of pharmaceutical products Walcourt · balance sheet 502,215 €
- Mecla Retail sale of pharmaceutical products Dour · balance sheet 502,903 €
- Zwitserse Apotheek Retail sale of pharmaceutical products Wijnegem · balance sheet 498,014 €
- Apoteek Diependale Retail sale of pharmaceutical products Oudenaarde · balance sheet 504,088 €
- Secundum Artem Retail sale of pharmaceutical products Etterbeek · balance sheet 496,587 €
Frequently asked questions about Verzele Pharma
What is the revenue of Verzele Pharma?
Verzele Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Verzele Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0896764703 for Verzele Pharma, if the company is VAT-registered. Its company number (CBE) is 0896.764.703.
Where is the registered office of Verzele Pharma?
According to the CBE register, the registered office of Verzele Pharma is in 9700 Oudenaarde.
What is the equity of Verzele Pharma?
At the close of the 2025 financial year, the equity of Verzele Pharma amounts to 166,349 €, a solvency of 33.2% of total assets.
How many people work at Verzele Pharma?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Verzele Pharma?
The register lists 5 active mandates at Verzele Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Verzele Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →